NIU.jpg
Niu Technologies Announces Unaudited Third Quarter 2024 Financial Results
18. November 2024 03:00 ET | NIU Technologies
-- Third Quarter Revenues of RMB 1,023.9 million, an increase of 10.5% year-over-year -- Third Quarter Net Loss of RMB 40.9 million, compared to Net Loss of RMB 79.4 million in the same period of...
ExAlt Loan Portfolio Charts
Beneficient Reports Results for Second Quarter Fiscal 2025
14. November 2024 16:45 ET | Beneficient
Beneficient today reported its financial results for the fiscal 2025 second quarter, which ended September 30, 2024.
agrify_logo_block.jpg
Agrify Corporation Announces Results for Third Quarter 2024
14. November 2024 16:03 ET | Agrify
Agrify Corporation Announces Results for Third Quarter 2024
stryve.png
Stryve Foods, Inc. Reports Fiscal 2024 Third Quarter Results
13. November 2024 16:15 ET | Stryve Foods, Inc.
Stryve Foods, Inc. (Nasdaq: SNAX) Reports Fiscal 2024 Third Quarter Results
FA_FullLogo_Horiz_FullColor_RGB@3x.png
First Advantage Reports Third Quarter 2024 Results
12. November 2024 06:30 ET | First Advantage Corporation
Third Quarter 2024 Highlights1 Revenues of $199.1 millionNet Loss of $(8.9) million, a net loss margin of (4.4)%, includes $13.2 million of expenses incurred related to the acquisition of Sterling...
MonoparTherapeuticsInc..png
Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
08. November 2024 08:00 ET | Monopar Therapeutics Inc.
In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials now Active and Enrolling Patients with Advanced Solid...
Logo.PNG
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
07. November 2024 08:00 ET | HilleVax, Inc.
$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...
Aveanna healthcare_500x262.png
Aveanna Healthcare Holdings Announces Third Quarter 2024 Financial Results and Revised 2024 Outlook
07. November 2024 06:30 ET | Aveanna Healthcare Holdings, Inc
Third Quarter Revenue was $509.0 million, a 6.5% increase over the prior year period Gross margin increased 8.4% to $159.7 million, compared to Q3 2023 Third Quarter Net loss was $42.8 million,...
INN_LogoTag_RGB.jpg
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2024
05. November 2024 16:05 ET | InnovAge
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2024
Pacific Health Care Organization, Inc. Reports its Third Quarter 2024 Results
05. November 2024 12:26 ET | Pacific Health Care Organization, Inc.
Irvine, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) last Friday filed with the Securities and Exchange Commission (the “Commission”) its...